Game da Mu - Qingdao Jianma Gene Technology Co., Ltd.

Bayanan Kamfanin

An kafa Qingdao Jianma Gene Technology Co., Ltd. a watan Fabrairu na shekarar 2019, Yana cikin Cibiyar Binciken Fasaha ta Masana'antu ta Babban Fasaha ta Qingdao, Lardin Shandong is Yana da harkar kimiyya da fasaha da ke mai da hankali kan R&D da samar da na'urorin likitanci a cikin filin POCT kwayoyin.

Kamfanin yana sanye da bita na tsabtace matakin 100,000 da manyan kayan bincike na kimiyya na duniya da kayan samarwa, kuma yana da bita mai girman murabba'in mita 1,200 da haɓakawa da samarwa.

Kamfanin yana da dandamali na fasahar gano nucleic acid guda biyu na musamman (Dandalin gano iskancin nucleic acid, dandalin ASEA nucleic acid da sauri) , Kayayyakin da aka haɓaka bisa wannan dandamali suna da halayen sauƙi, saurin sauri, babban takamaiman yanayi, da babban hankali. An sami nasarar amfani da shi a fannoni da yawa kamar lafiyar likita, amincin abinci, cutar dabbobi da sauransu.

Dogaro da dandamali na fasaha na sama, muna haɓaka kayan aikin gano ƙwayoyin nucleic acid na hannu waɗanda ba su dogara da kayan aiki masu rikitarwa, waɗanda ake tsammanin za a yi amfani da su don gano likitan iyali da tushen ciyawa a nan gaba.

CIA(AZV952I~V5%XUC50~LI
C[5X{X6$0W12D7}Y]_{91Q9
AH6)N]%5(8IG2$MDQ)Z`9EV
_FFD8779DFMXVGMCXG405$2

Sabbin buƙatun don rigakafi da sarrafa cutar ta SARS-CoV-2 da matsayin kasuwancin

Yayin da annobar duniya ke ci gaba da haɓaka, rigakafin annoba da sarrafawa ya shiga matakin daidaitawa.

Don amsawa da kyau ga halin da ake ciki yanzu da kuma cika buƙatun gwajin acid nucleic a cikin yanayi daban-daban, Ya zama dole don hanzarta bincike da haɓakawa da ƙungiyar samarwa, ƙaddamar da ƙarin samfuran haɗaɗɗu da sauri-gwaji waɗanda suka dace don gwajin gidan yanar gizo, da inganta samfuran gwajin ƙwayoyin nucleic acid na ƙasata da tsarin fasaha.

A ranar 29 ga watan Yuli, firaministan kasar Li Keqiang ya karbi bakuncin taron zartarwa na majalisar gudanarwar kasar, domin tabbatar da cikakken shirin rigakafin annoba da raya kasa, an yi shirye -shiryen kara karfafa ginin karfin gwajin sinadarin nucleic.

Taron ya yi nuni da cewa ya zama dole a tattara dukkan bangarorin don hanzarta haɓakawa da ƙaddamar da samfuran cikin ɗan gajeren lokaci, babban hankali da aiki mai sauƙi.Ta haɓaka horon ma'aikatan dubawa da haɓaka ƙarfin binciken wayar hannu da kyau, Don gwajin ƙwayar nucleic acid na marasa lafiya a asibitocin zazzabi, yi ƙoƙarin rage rahoton zuwa awanni 4.

A lokacin barkewar cutar SARS-CoV-2 annoba, ƙungiyar Jianma Gene Technology Co., Ltd. ta yi aiki tare da Jami'ar Kimiyya da Fasaha ta Qingdao da Jami'ar Qingdao don bincika manyan matsalolin, haɓaka samfuran gano ƙwayoyin acid, da samun ganowa cikin kusan mintuna 30.

A ranar 13 ga Maris, 2020, kayan COVID-19 sun sami takaddar CE ta EU; A watan Mayu, ta sami cancantar fitarwa na sabon masana'anta mai gwajin gwajin kambi na Ma'aikatar Kasuwancin China.

Tambarin samfur mai amfani da ƙwayoyin cuta guda ɗaya da kamfaninmu ya samar yana ɗaukar mintuna 3 kawai don kammala sarrafa samfuri da hakar mai sauri.A halin yanzu, an kammala shigar da samfuran na'urorin likitanci na Class I.Saurin gano samfuran acid na hanzari da kamfani ya haɓaka ya rage lokacin gano nucleic acid zuwa mintuna 30, wanda ke cika cikakkiyar rigakafin cutar da buƙatun sarrafawa da buƙatun zamantakewa.A halin yanzu, an fitar da samfuran gwajin COVID-19 cikin sauri zuwa Indonesia, Brazil da wasu ƙasashe, kuma abokan ciniki sun gane su.

4
2
3